Observational studyFrontiers in immunology2025

Natalizumab and fumarate treatment differentially modulate CD4+ T cell and B cell subtypes in multiple sclerosis patients without impacting durable COVID-19 vaccine responses.

Ryan Curtin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.